| [1]何广辉,李燕.新生血管性青光眼的临床诊疗现状[J].眼科新进展,2014,34(10):997-1000.
HE G H,LI Y.Clinical status of neovascular glaucoma[J].Recent Advances in Ophthalmology,2014,34(10):997-1000.
[2]WENGER R H.Cellular adaptation to hypoxia:O2-sensing protein hydroxylases,hypoxia-inducible transcription factors and O2-regulated gene expression[J].FASEB,2002,16(10):1151-1162.
[3]张波.新生血管性青光眼不同手术疗法的疗效对比[J].国际眼科杂志,2010,10(4):671-673.
ZHANG B.Contrast of surgical effect of two different operations for neovascular glaucoma[J].International Journal of Ophthalmology,2010,10(4):671-673.
[4]孙怡,赵海霞,关文英,等.新生血管性青光眼研究进展[J].临床和实验医学杂志,2016,13(13):1344-1345.DOI:10.3969/j.issn.1671-4695.2016.13.035.
[5]HAYREH S S.Neovascular glaucoma[J].Prog Retin Eye Res,2007,26(5):470-485.
[6]KIDDEE W,TANTISARASART T,WANGSUPADILOK B.Neovascular glaucoma:a retrospective review of 5-year experience in Songklanagarind Hospital[J].J Med Assoc Thai,2012,95:S36-42.
[7]刘薇,华琳,张雪莲,等.2型糖尿病患者C肽水平与糖尿病视网膜病变的关系研究[J].中国全科医学,2013,16(8):2667-2670.
LIU W,HUA L,ZHANG X L,et al.Relationshi of C peptide level to diabetic retinopathy in T2DM patients[J].Chinese General Practice,2013,16(8):2667-2670.
[8]刘国军,庞凤,杜敏晖,等.视网膜中央静脉阻塞与糖尿病视网膜病变所致新生血管性青光眼的临床特点分析[J].中华实验眼科杂志,2013,31(10):968-972.
LIU G J,PANG F,DU M H,et al.Clinical characteristics of neovascular glaucoma secondary to central retinal vein occlusion and diabetic retinopathy[J].Chinese Journal of Experimental Ophthalmology,2013,31(10):968-972.
[9]韩姬,王玲,刘伟仙,等.康柏西普玻璃体腔注射对糖尿病视网膜病变患者视力的影响[J].中国全科医学,2015,10(5):502-506.
HAN J,WANG L,LIU W X,et al.Effects of compaq sipp intravitreal injection on visual acuity of diabetic retinopathy[J].Chinese General Practice,2015,10(5):502-506.
[10]DESCHLER E K,SUN J K,SIIVA P S.Side-effects and complications of laster treatment in diabetic retinal disease[J].Semin Ophthalmol,2014,29(5/6):290-300.
[11]WENGER R H,STIEHL D P,CAMENISCH G.Integration of oxygen signaling at the consensus HRE[J].Sci STKE,2005,2005(306):re12.
[12]蒋瑶祁,彭辉灿.VEGF家族及其受体与视网膜新生血管形成[J].国际眼科杂志,2006,6(5):1113-1116.
JIANG Y Q,PENG H C.Vascular endothelial growth factor family & receptors and retinal neovascularization[J].International Journal of Ophthalmology,2006,6(5):1113-1116.
[13]李莉,刘升强,王帅,等.血清及房水VEGF、IL-6水平与新生血管性青光眼的相关性研究[J].临床眼科杂志,2011,19(6):490-493.
LI L,LIU S Q,WANG S,et al.Study of the correlation between serum,aqueous humor VEGF,IL-6 levels and the neovascular glaucoma[J].Journal of Clinical Ophthalmology,2011,19(6):490-493.
[14]TRIPATHI R C,TRIPATHI B J.Tissue plasminogen activator therapy for the eye[J].Br J Ophthalmol,2005,89(11):1390-1391.
[15]谢静,曾祥云.VEGF、EPO与新生血管性青光眼[J].赣南医学院学报,2015,35(2):321-324.DOI:10.3969/j.issn.1001-5779.2015.02.053.
[16]WATANABE D,OTANI N,SUZUKI S,et al.Evaluation of VZV-specific cell-mediated immunity in adults infected with HIV-1 by using a simple IFN-γ release assay[J].J Med Virol,2013,85(8):1313-1320.
[17]ZHU B,WANG W,QN Q,et al.Erythropoietin protects retinal neurons and glial cells in early-stage streptozotocin-induced diabetic rats[J].Exp Eye Res,2008,86(2):375-382.
[18]朱弼珺,王卫峻,许迅.RhEPO对早期糖尿病大鼠视网膜超微结构和EPO-R表达的影响[J].眼科新进展,2007,27(8):581-584.
ZHU B J,WANG W J,XU X.Alteration of ultrastructure in retinal neurons and expression of retinal erythropoietin receptors of early stage diabetic rats with protection effects of erythropoietin[J].Recent Advances in Ophthalmology,2007,27(8):581-584.
[19]刘晓静,朱弼珺,邹海东,等.氨甲酰促红细胞生成素防治糖尿病视网膜病变的作用及机制[J].中华实验眼科杂志,2014,32(11):980-988.
LIU X J,ZHU B J,ZOU H D,et al.Carbamylated erythropoietin-mediated protective effect on diabetic retinopathy and underlying mechanism[J].Chinese Journal of Experimental Ophthalmology,2014,32(11):980-988.
[20]FANDREY J,HALLEK M.Erythropoiesis:physiology,pathophysiology,and algorithm for classification of the type of anemia[J].Internist (Berl),2015,56(9):970-977.
[21]AURICCHIO A,ROLLING F.Adenoma-associated viral vectors for retinal gene transfer and treatment of retinal diseases [J].Curr Gene Ther,2005,5(3):339-348.
[22]尚郡主,成宵黎.原发性开角型青光眼患者房水和血清中促红细胞生成素水平的研究[J].山西医药杂志,2009,38(4):318-319.DOI:10.3969/j.issn.0253-9926.2009.04.012.
[23]HOLLBORN M,REHAK M,IANDIEV I,et al.Transcriptional regulation of aquaporins in the ischemic rat retina:upregulation of aquaporin-9[J].Curr Eye Res,2012,37(6):524-531.
[24]BECERRA S P,AMARAL J.Erythropoietin-an endogenous retinal survival factor[J].N Engl J Med,2002,347(24):1968-1970.
[25]吕明良,李敏.IGF-1对人RPE细胞HIF-1α及VEGF表达的影响[J].眼科新进展,2011,31(7):625-628.
LYU M L,LI M.Effect of insulin-like growth factor-1 on expression of hypoxia inducible factor-1α and vascular endothelial growth factor in cultured human RPE cells[J].Recent Advances in Ophthalmology,2011,31(7):625-628.
[26]颜华,崔靖,于金国,等.增生性糖尿病视网膜病变患者玻璃体内血管内皮生长因子的表达[J].中华眼科杂志,2009,45(3):206-209.
YAN H,CUI J,YU J G,et al.The expression of vascular endothelial growth factor of vitreous in patients with proliferative diabetic retinopathy[J].Chinese Journal of Ophthalmology,2009,45(3):206-209.
[27]苏钰,陈长征,李璐,等.增生型糖尿病视网膜病变患者玻璃体血管内皮生长因子及其受体浓度检测[J].中华眼底病杂志,2012,28(3):289-290.DOI:10.3760/cma.j.issn.1005-1015.2012.03.020.
[28]BOCK F,KONIG Y,DIETRICH T,et a1.Inhibition of angiogenesis in the anterior chamber of the eye[J].Ophthalmology,2007,104(4):336-344.
[29]胡海晨.糖尿病视网膜病变玻璃体中EPO及VEGF表达水平的研究[D].北京:中国协和医科大学,2006.
[30]TRIPATHI R C,LI J,TRIPATHI B J,et al.Increased level of vascular endothelial growth factor in aqueous humor of patients with neovascular glaucoma[J].Ophthalmology,1998,105(2):232-237. |